← Back

Wire · opportunities

FDA shares warning about stroke prevention device after injury

Published

27 July 2026

Topic

opportunities

Sectors

Medtech

Geography

United States

Source

Read at cardiovascularbusiness.com

Verified

Fusion42 · 28 July 2026 · Fusion42 review

The FDA issued an early warning about Boston Scientific's Enroute Transcarotid Neuroprotection System catheters after identifying a risk of arterial sheath tip separation during use, which can lead to stroke or other serious complications. At least one injury has been reported, and affected devices must be removed from clinical use and returned to the manufacturer.

This Wire brief sits within Fusion42's coverage of Medtech. Wire is Fusion42's founder-focused intelligence feed: each story is connected to the funds and startups it names — every one with a live profile on Raise or Scout — so founders can follow the capital and the momentum behind the headline rather than just the headline itself. Wire analysis is one of the live surfaces Arthur reasons over.

◆ The Wire takeaway

Boston Scientific's transcarotid stroke prevention device is being pulled from use due to tip separation risk. If you make a competing transcarotid system or carotid intervention tool, hospitals currently using Enroute need an alternative immediately—and they're locked in mid-procedure protocols.

Related on Wire

Topics

Medtechdevice-recallfda-warninginterventional-cardiologyproduct-safetyvascular-surgery